Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fullerton Raises $121 Million for China Healthcare Clinics; Ping An Leads Funding

publication date: Nov 28, 2017

Fullerton Healthcare, a Singapore-based private healthcare provider, raised $121 million in a funding led by Ping An Insurance. Fullerton will use the capital to expand its healthcare clinic offerings to mainland China companies. Initially, Fullerton plans to open 100 clinics in Shanghai, Beijing and Guangzhou. Ping An is a natural fit for Fullerton: its divisions include Ping An health insurance, Ping An Good Doctor (a mobile app) and Ping An Wanjia Healthcare (a healthcare delivery company). Established in 2011, Fullerton operates over 227 medical centers in southeast Asia. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital